↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
HawkEye 360$HAWK · filed: 🫧 Edgar looked up HawkEye 360Check ▾Close ▴
What HawkEye 360 filed
🫧 Edgar looked up HawkEye 360, Inc. ($HAWK). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-11-10. 5 event filings (8-K) in the past twelve months. Every figure links to the filing it came from on HawkEye 360’s card.
Figures as filed with the SEC. Ranges, scores and boats are statistical descriptions of past filings, not ratings or recommendations. Reporting, not advice.
In plain words
Two mid-market IPOs test primary issuance appetite after four-month freeze; pricing discipline suggests reconnaissance, not reopening.
$14
Wednesday evening
$149.1 million
in the first notable defense-tech IPO since Palantir's secondary…
$16
the low end of its
$104 million
Both offerings mark the first meaningful primary issuance since…
HawkEye 360, the Herndon-based radio frequency satellite operator, priced 10.65 million shares at $14 Wednesday evening, raising $149.1 million in the first notable defense-tech IPO since Palantir's secondary offering in December. Seaport Therapeutics, a CNS-focused biotech, priced 6.5 million shares at $16, the low end of its $16-$18 range, for $104 million. Both offerings mark the first meaningful primary issuance since January's post-inauguration freeze.
HawkEye's pricing came at the midpoint of its $13-$15 range, suggesting measured but not enthusiastic demand. The company operates a constellation of 21 satellites detecting and geolocating RF signals—vessel transponders, radar emissions, push-to-talk radios—and sells that intelligence to defense, maritime, and commercial clients. Revenue grew 41% year-over-year to $53.8 million in 2024, while net loss narrowed to ($32.1 million) from ($38.4 million). The offering values HawkEye at roughly $576 million pre-money, a 10.7x trailing revenue multiple, compressed from the 12-14x that space infrastructure names commanded in 2021-2022. Underwriters include Morgan Stanley, BofA Securities, and William Blair.
Seaport's biotech offering reflects a different risk calculus. The company's lead asset, SPN-830, is a GABA-A modulator in Phase 3 trials for post-partum depression, with topline data expected in Q2 2025. Pricing at the low end signals investor caution around near-term binary events, particularly after a string of CNS trial failures in late 2024 eroded speculative capital for neuroscience plays. The company now holds $154 million in cash, enough for 18-20 months of runway through the Phase 3 readout and a potential Phase 2 initiation in major depressive disorder.
What matters is not the size of these offerings but their existence. The IPO window has been functionally closed since October, when Klarna's confidential filing leaked and Silicon Valley Bank's collapse anniversary prompted a risk-off posture among long-only funds. HawkEye and Seaport are testing whether post-election clarity and a stable rate environment can sustain primary issuance for companies with visible revenue or near-term catalysts. The pricing discipline—no upsizing, no range increases—suggests bankers are managing expectations tightly. This is not exuberance. This is reconnaissance.
Operators should watch for aftermarket performance through the first 10 trading days, particularly whether HawkEye holds its midpoint pricing or trades down toward $12-$13, which would signal that even defense-adjacent growth stories face valuation compression. Seaport's action around the May 15 data readout will set tone for biotech IPOs with near-term milestones. If either offering trades poorly, expect the window to re-close through Q2 earnings season.
The IPO market is not open. It is ajar, and the door hinges are still cold.
Branded by POPS4 · proof in 60 seconds
For the principal
Watch these names for liquidity lessons, not direct exposure—IPO windows signal when secondaries and late-stage privates regain pricing power.
For the operator
Track aftermarket performance through day ten; if either breaks issue price, shelve primary fundraise plans until late Q2.
For the house
No allocation interest at these multiples; monitor secondary discounting in space-infrastructure and CNS biotech for distressed entry opportunities.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.